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Confronting the complexities of the new century, clinical
microbiology (CM) is developing in various directions.
According to its original meaning, CM primarily deals with
the aetiological diagnosis of human and animal infections, and
it also goes as far as to suggest the possible outcome of the
infectious process in any individual patient for whom a given
antimicrobial treatment is considered. Since the early phases
of CM, these tasks and their accomplishment have
always followed, and have been regulated by, Koch’s classic
postulates.
Because, by deﬁnition, infectious diseases may be trans-
mitted from a patient to a novel subject, CM, by its own
nature, has a public health (PH) dimension. Nobody would
argue against this PH dimension in the hospital setting,
where CM does indeed play a key role in preventing and
controlling hospital-acquired infections [1,2]. Nonetheless,
one should consider that hospitals are not isolated institu-
tions but are ecologically (and epidemiologically) linked with
other hospitals and long-term-care facilities, and with an
‘infectable’ community at large. A considerable body of
evidence has now conﬁrmed the extent to which any intra-
hospital microbiological event may have wide-ranging PH
consequences in several external compartments, from
neighbouring wards to the entire extra-hospital community.
Conversely, any biological change occurring anywhere out-
side the hospital—from the emergence of new pathogens
or novel antibiotic resistance mechanisms, to demographic
changes in the human or animal population, to micro-
variations or macro-variations in the climate, to the use of
antibiotics in the food chain—will sooner or later impact
on the ecology of CM within the hospital [3]. Thus, in
recent years, hospital-based CM specialists have been more
and more frequently involved in initiatives aimed at under-
standing and controlling phenomena such as the widespread
dissemination of microbial clones endowed with particular
virulence or antimicrobial resistance, or the dynamics
of mobile genetic elements involved in either antibiotic
resistance or virulence, or aimed at establishing the
extra-hospital origin of new microorganisms, or monitoring
and controlling the use of antimicrobial drugs or vaccines
[4,5]. In all of these initiatives, CM specialists have more
often than not held a leading position.
All of this can be regarded as PH microbiology (PHM), in
which activities such as elucidating the population structure
of a collection of clones, classifying plasmids, transposons or
integrons, or identifying novel b-lactamases are not aimed at
improving the diagnosis and therapy of individual infected
patients, but can be seen—and are fully justiﬁed—in the
framework of a PH perspective [4,6]. The current involve-
ment of CM in diagnosing the new A(H1N1) inﬂuenza cases,
sequencing viral genomes, tracing the origin of the strain and
monitoring the emergence of resistance to antiviral agents is
a prominent example of PHM.
One should be aware that two opposite forces, one
positive and one negative, are currently driving the PH
dimension of CM. On the one hand, PHM is being nour-
ished by the multiple networks of hospital CM laboratories
enrolled in national and international surveillance pro-
grammes, representing, to date, the only feasible way of
obtaining comprehensive data about the epidemiology,
ecology and evolution of infectious diseases [7]. On the
other hand, participation of individual hospitals in these
PHM activities is constantly at risk of being no longer fun-
ded—or even of being frankly opposed—by hospital man-
agement teams facing continuous budget restrictions, with
the justiﬁcation that these tasks should be performed by
central reference laboratories, or alternatively funded as
‘research projects’ by either national or international fund-
ing agencies.
A realistic view of the current PHM landscape could be
outlined as follows:
1. The complexity and the spatial–temporal variability of
microbiological events that might be signiﬁcant for PH
interventions both require a broad network of estab-
lished sampling and surveillance sites, and this can be
currently accomplished only by recruiting CM laborato-
ries based in the individual hospitals (which frequently
also cover the community department). The emergence
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or re-emergence of new microbial alerts also needs to
be carefully monitored to allow urgent interventions to
be made [7,8].
2. Microbiological data of PH interest that are obtained at
the hospital level should be primarily used and adver-
tised locally, with analysis and divulgence of the clinical
and epidemiological ﬁndings, and with the establishment
of permanent local collections (biobanks) of signiﬁcant
strains, i.e. a type of information that would be lost or
diluted in the central reference laboratories.
3. It is obvious that not all hospitals in Europe host micro-
biological laboratories that are equally trained or
equipped in advanced PHM techniques (to mention only
a few: clonal detection, sequencing, or using bioinformat-
ics tools and mathematical modelling).
4. The acquisition of increasing PHM responsibilities by
hospital-based CM laboratories should not be perceived
as a threat to the role of central reference laboratories;
on the contrary, regional reference laboratories—serving
as nodes of local hospital networks—should be encour-
aged and developed.
In conclusion, it seems reasonable to propose the ofﬁcial
assessment and regulation of the PH roles played and of the
duties assumed by hospital-based CM laboratories. These
roles and duties vary, largely depending on the local needs
and resources, and range from mere collection and storage
of routine data (by means of archive-only informatics net-
works) to analytical work on the population biology of
microbial pathogens, mechanisms of pathogenesis, epidemige-
nicity or antibiotic resistance [2,9]. To a certain extent, all
this would imply the formal recognition of a speciﬁc branch
of CM, namely PHM, and the implementation of resources
to ensure its regular functioning in the hands of dedicated
microbiologists.
Centralized PH services on our continent (such as the
European Centre for Disease Control) are well aware of the
need to develop PHM activities at the hospital level, and con-
cepts in this ﬁeld are being actively developed (http://
www.ecdc.europa.eu/en/activities/microbiology/Pages/Activities
_MicrobiologyCooperation.aspx). The absence of a central-
ized high-level PHM institute in Europe (such as the
CDC in the USA) could represent a paradoxical advantage
for our continent. A future European network of
decentralized PHM laboratories might be much more
plastic and, as such, able to trace the natural history of
pathogenic microorganisms and infectious diseases, being
at the same time more attuned to detect emergences
and rapidly changing trends and to suggest speciﬁc local
interventions.
But there is something more. The urgent need for PHM
also represents an opportunity and a challenge in shaping the
future of CM as a whole. Beyond the obvious need to look
after individual infected patients, and the local task of moni-
toring hospital epidemiology (with special but not exclusive
reference to intensive-care units), CM specialists should also
investigate the multiple inﬂuence of pathogenic microorgan-
isms in the community at large.
In a way, we could say that the traditional patient-based
or ward-based CM should continue to act as the ‘ﬁeld
microbiology’, i.e. ensure the direct observation of phenom-
ena. PHM, using a mixture of analytical procedures (e.g. sub-
speciﬁc typing) and synthetic procedures (e.g. phylogeny
studies), should investigate both the causes and the evolution
of microorganism–host interactions.
It should be pointed out that all processes active beyond
the individual patients are driven by the biotic environments
of these same patients, i.e. other patients, but also their
relatives, healthy people, animal contacts, and all sociologi-
cal, geographical, physical and chemical environments at
large. Similarly, microorganisms are composed not only of
individual genes, but different genetic consortia; they are
not only cells, but populations; not only species, but inter-
active communities, also undergoing changes related to the
environmental changes. That is why PHM overlaps with the
territory of ecology at large (‘public health ecology’?), and
all those involved in it should be aware of the need to
increasingly share concepts and methods that are typical
of the many emerging novel disciplines devoted to the
understanding (and eventually to the prediction) of the life
processes (Fig. 1).
The ﬁrst of these disciplines is microbial population biol-
ogy, comprising population genetics (gene frequencies, vari-
ability and micro-evolution), population ecology (structure
and dynamics of populations in different environments) and
population metagenomics (genetic structure of microbial
communities in the host population). Obviously, the ﬁnal goal
of this whole epistemological ensemble is predictive evolu-
tionary biology, which should be able to predict (and hence
prevent) possible harmful trends in the relationships between
microorganisms and humankind [10].
This whole collection of conceptual and methodological
elements should not be regarded as mere philosophical
architecture, but is now urgently required to reassess and
update the role of the old ‘epidemiology’ so as to convert it
into a modern science. The future PHM should develop itself
in this multifaceted epistemological landscape, and facilitat-
ing such a huge task is among the major scientiﬁc
challenges now facing CM specialists in a world of increasing
complexity.
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FIG. 1. A comprehensive view of the scientiﬁc ﬁelds in which public health microbiology (PHM) should be rooted in the future. Note that the
trans-individual dimension of PHM draws this discipline close to sciences involved in the maintenance and control of the healthy ecological inter-
actions between humans and microorganisms.
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